Accelerating Innovation on Antimicrobial Resistance
The CSIS Bipartisan Alliance for Global Health Security will host a public webcast conversation on Wednesday, June 21 from 10:00am to 12:00pm ET aimed at identifying specific opportunities to advance transatlantic cooperation on mitigating the threat of antimicrobial resistance (AMR). A series of two panels will consider opportunities for greater transatlantic cooperation on AMR and steps to accelerate and sustain R&D of new technologies. The full list of featured speakers is included below.
Sandra Gallina, Director General of the Directorate-General for Health and Food Safety (SANTE) at the European Commission offers a powerful video message on the need to strengthen attention to and action on antimicrobial resistance. The video follows the recording embedded above.
This event is made possible by the generous support of Merck & Co., Inc.
J. Stephen Morrison, Senior Vice President and Director, CSIS Global Health Policy Center
Panel I: The Power of Transatlantic Cooperation
Ingrid Keller, Head of Unit for Health Security, Directorate-General for Health and Food Safety (DG SANTE), European Commission
Colin McIff, Deputy Assistant Secretary, Office of Global Affairs, U.S. Department of Health and Human Services
Linda Ristani, Director of AMR Global Engagement and Innovation, Public Health Agency of Canada
Moderator: Julie Gerberding, CSIS Alliance Co-Chair and CEO, Foundation for the National Institutes of Health
Panel II: Accelerating and Sustaining R&D of New Antibiotics and Technologies
Malin Grape, Swedish AMR Ambassador
Christopher Houchens, Director, Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA)
Wolfgang Philipp, Head of Unit, European Health Emergency Preparedness and Response Authority (HERA)
Moderator: Krishna Udayakumar, Founding Director, Duke Global Health Innovation Center and Associate Professor of Global Health and Medicine, Duke University